Literature DB >> 30964006

Nanomedicine for anticancer and antimicrobial treatment: an overview.

Shatavari Kulshrestha1, Asad U Khan2.   

Abstract

Nanoparticle-based treatment has become a potential therapeutic approach. The nanosize of these particles provides them with unique physicochemical properties and enhances their interaction with the biological system. Nanomaterials have the potential to overcome some of the major issues in the clinical world which may include cancer treatment and may be utilised to resolve the major problem of drug resistance in infection control. These particles are being used to improve present therapeutics by virtue of their shape, size and diverse intrinsic as well as chemical properties. The authors have discussed the use of nanoparticles in cancer treatment, infections caused by multidrug-resistant microbial strains and biofilm inhibition along with the detailed description of the current status of nanomaterials in the field of medicine.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30964006      PMCID: PMC8676473          DOI: 10.1049/iet-nbt.2018.5112

Source DB:  PubMed          Journal:  IET Nanobiotechnol        ISSN: 1751-8741            Impact factor:   1.847


  107 in total

1.  Toxicity of graphene and graphene oxide nanowalls against bacteria.

Authors:  Omid Akhavan; Elham Ghaderi
Journal:  ACS Nano       Date:  2010-10-26       Impact factor: 15.881

Review 2.  Applications of Nanoparticles for Anticancer Drug Delivery: A Review.

Authors:  Yuanyuan Zhu; Lianming Liao
Journal:  J Nanosci Nanotechnol       Date:  2015-07

Review 3.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

4.  Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat.

Authors:  Morteza Mahmoudi; Vahid Serpooshan
Journal:  ACS Nano       Date:  2012-03-07       Impact factor: 15.881

5.  Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress.

Authors:  Shaobin Liu; Tingying Helen Zeng; Mario Hofmann; Ehdi Burcombe; Jun Wei; Rongrong Jiang; Jing Kong; Yuan Chen
Journal:  ACS Nano       Date:  2011-08-24       Impact factor: 15.881

6.  Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli.

Authors:  Sukdeb Pal; Yu Kyung Tak; Joon Myong Song
Journal:  Appl Environ Microbiol       Date:  2007-01-19       Impact factor: 4.792

Review 7.  Polymeric micelles - a new generation of colloidal drug carriers.

Authors:  M Jones; J Leroux
Journal:  Eur J Pharm Biopharm       Date:  1999-09       Impact factor: 5.571

Review 8.  Current advances in research and clinical applications of PLGA-based nanotechnology.

Authors:  Jian-Ming Lü; Xinwen Wang; Christian Marin-Muller; Hao Wang; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2009-05       Impact factor: 5.225

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

10.  Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer.

Authors:  L Paz-Ares; H Ross; M O'Brien; A Riviere; U Gatzemeier; J Von Pawel; E Kaukel; L Freitag; W Digel; H Bischoff; R García-Campelo; N Iannotti; P Reiterer; I Bover; J Prendiville; A J Eisenfeld; F B Oldham; B Bandstra; J W Singer; P Bonomi
Journal:  Br J Cancer       Date:  2008-05-13       Impact factor: 7.640

View more
  1 in total

Review 1.  Use of nanoparticles in skeletal tissue regeneration and engineering.

Authors:  Miriam Filippi; Gordian Born; Delphine Felder-Flesch; Arnaud Scherberich
Journal:  Histol Histopathol       Date:  2019-11-13       Impact factor: 2.303

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.